Group 1 - US stock market showed mixed results with Nasdaq and S&P slightly up while Dow Jones declined, Intel's stock plummeted by 17% due to poor earnings guidance, while Nvidia and other chip stocks provided support [1] - The dollar index continued to weaken, and gold futures reached an all-time high, with silver breaking the $100 mark for the first time, driven by severe weather that caused US natural gas prices to surge by 70% in a week [1] - European countries hold approximately $3.6 trillion in US Treasury bonds, representing 40% of the overseas total, which could be used as leverage against the US amid tariff pressures, although coordinated selling may lead to significant losses [2][19] Group 2 - Japanese Prime Minister Fumio Kishida's tax cut promises have raised market concerns, leading to a massive sell-off of Japanese government bonds, causing long-term bond yields to soar to multi-year highs [3][20] - The US oil service giant SLB stated it could quickly expand operations in Venezuela if permitted, being the only international oil service company currently operating there, with competitors like Halliburton also looking to re-enter the market [4][21] - Canadian billionaire Eric Sprott has significantly profited from investing in the struggling Hycroft Mining Company, with a return on investment of 678%, capitalizing on the bull market for gold and silver [5][22] Group 3 - Silver prices have historically surpassed $100 per ounce, with a year-to-date increase of 40%, driven by strong industrial demand and ongoing structural supply shortages [6][23] - Economists have revised their expectations, indicating that the Federal Reserve may delay interest rate cuts until June, with inflation pressures and a robust labor market reducing the urgency for rate reductions [7][24] - Nomura's chief economist suggested gradually increasing farmers' pensions to 1,000 yuan per month, which could significantly improve rural elderly income expectations and stimulate consumption [8][25] Group 4 - The A-share market saw a surge in the photovoltaic sector, with major investment from well-known funds in commercial aerospace and semiconductor industries, indicating a strong institutional interest [10][26] - Musk's support for space-based solar power has led to a significant rally in photovoltaic stocks, with over 30 stocks hitting the daily limit up, although the industry still faces substantial technical and cost challenges [11][28] - China Merchants Bank has become the first bank to surpass 13 trillion yuan in total assets, indicating a potential turning point in its financial performance, while other banks also reached significant asset milestones [12][29]

● 本报记者 董添 1月23日，国务院新闻办公室举行新闻发布会，介绍2025年知识产权工作进展情况。国家知识产权局相 关负责人透露，截至2025年底，我国国内（不含港澳台）发明专利有效量达到532万件。其中，人工智 能专利有效量居全球前列。 创新质量持续提升 国家知识产权局副局长芮文彪介绍，2025年共授权发明专利97.2万件，实用新型专利146.1万件，外观设 计专利66.6万件。专利复审和无效结案9.6万件。发明专利审查周期压减至15个月，结案准确率提升至 95.6%。截至2025年底，我国国内（不含港澳台）发明专利有效量达到532万件，每万人口高价值发明 专利拥有量达到16件。专利密集型产业增加值占GDP比重升至2024年的13.38%，超额完成知识产权"十 四五"规划预期目标。 芮文彪表示，上述数据反映出，我国创新质量持续提升。我国国内（不含港澳台）有效发明专利中，高 价值发明专利同比增速比总体水平高2.2个百分点，数量达到229.2万件。信息技术管理方法、计算机技 术、医学技术等领域的有效发明专利增速居前，人工智能专利有效量居全球前列，在量子科技、生物制 造、脑机接口、第六代通讯等未来产业布局了一批 ...

1月23日，国家知识产权局副局长芮文彪在国新办举行的新闻发布会上表示，截至2025年底，我国国内 (不含港澳台)发明专利有效量达到532万件，每万人口高价值发明专利拥有量达到16件。 专利密集型产业是布局新赛道、培育新动能的重点领域。芮文彪介绍，我国专利密集型产业的增加值突 破18万亿元，占GDP的比重从2020年的11.97%提升到2024年的13.38%，对经济增长的贡献度稳步提 高。 国家知识产权局战略规划司司长梁心新补充说，目前，我国专利密集型产业创新驱动特征明显。专利密 集型产业的创新投入持续增强，创新要素加速集聚。2024年研发投入强度超过2.6%，是非专利密集型 产业的2.4倍。同时，专利产出水平也在同步提升，创新成果密集涌现。专利密集型产业每万名就业人 员最近五年的发明专利授权量达到476件，同比提高66件，是全国产业平均水平的10倍。另外，数字产 业地位凸显。数字经济相关产业在专利密集型产业中的占比持续提升，信息通信技术制造业和信息通信 技术服务业的增加值合计近8万亿元，占整体比重超过四成。新装备制造业、医药医疗、环保等新兴产 业的增加值也在稳步提升，反映出我国产业发展正在加快向高端化、智能 ...

Core Viewpoint - The company, Kangzhi Pharmaceutical (300086.SZ), has stated that it currently has no projects in collaboration with brain-computer interface companies [1] Group 1 - The company confirmed its lack of partnerships with brain-computer interface firms as of now [1]

Group 1 - The overall positioning of public funds has become clearer with the completion of the 2025 Q4 reports, showing a notable shift towards cyclical and small-cap growth stocks, while the allocation to Hong Kong stocks has decreased significantly from 19.26% to 16.23% [1] - The decline in the strategic position of Hong Kong stocks within active equity funds contrasts with the upward trend in the A-share market, raising concerns about the future performance of Hong Kong stocks [1] - The A-share market has shown a strong growth style, with significant thematic investment in sectors like commercial aerospace and artificial intelligence hardware, which are less represented in the Hong Kong market [2] Group 2 - Hong Kong stocks are facing dual pressures on liquidity, both from external factors and southbound capital, making them more sensitive to liquidity changes compared to A-shares [3] - Despite a record inflow of 1.4 trillion RMB from southbound capital in 2025, the pace has slowed significantly in Q4, with daily average inflows dropping to 10.9 million HKD in December [3] - The IPO market in Hong Kong has thrived, with 117 IPOs raising 285.9 billion HKD in 2025, marking a return to the top globally, but a potential wave of lock-up expirations could pose challenges [4][5] Group 3 - The upcoming lock-up expirations for major companies listed in the first half of 2025 could lead to significant selling pressure, with an estimated 120 billion HKD in potential unlocks by December [4] - Historical patterns indicate that lock-up expirations have coincided with declines in the Hong Kong market, although strong-performing companies may still attract new investments [5] - The market's current dynamics suggest that while there may be selling pressure from lock-up expirations, the presence of new buying forces could offset this impact [5]

Core Viewpoint - The company is actively focusing on modern frontier medical technologies, including smart healthcare and brain-computer interfaces, as indicated by its recent patent application in the field [1]. Group 1: Company Developments - The company has applied for a patent related to a DAC-GAN model construction method and its application in breast MR imaging [1]. - The primary function of the patented technology is to acquire and process breast MR image datasets, constructing a DAC-GAN model to predict breast MR images [1].

Group 1 - The core viewpoint of the article is that the company, Wuchan Zhongda, is actively exploring technology in the elderly care sector through collaboration with Strong Brain Technology, applying brain-computer interface technology to its elderly care business [1] Group 2 - Wuchan Zhongda's subsidiary, Wuchan Zhongda Jinshi Group Co., Ltd., is leading the initiative in technological advancements for elderly care [1] - The partnership with Strong Brain Technology signifies a strategic move towards integrating advanced technology into the company's services [1] - The focus on brain-computer interface technology indicates a commitment to enhancing the quality of elderly care through innovative solutions [1]

Core Viewpoint - The brain-computer interface (BCI) industry is identified as a long-term investment opportunity in the healthcare sector, with significant strategic importance for the company in the medical device field [1] Summary by Relevant Sections Industry Outlook - The implementation opinions jointly issued by seven departments, including the Ministry of Industry and Information Technology, aim to establish an advanced technology, industry, and standard system for the BCI industry by 2027, and to cultivate 2 to 3 globally influential leading enterprises by 2030 [1] Company Strategy - The company has been researching and exploring the BCI direction since 2023 and strategically invested in Hangzhou Qingshi Yongjun in 2025, successfully entering the invasive BCI treatment field for severe treatment-resistant depression [1] - The recent investment in Haoshi Tianhui further enhances the company's detection and treatment layout for depression and anxiety disorders within the BCI field [1] Future Plans - The company plans to continue its strategic layout in the BCI field by participating deeply through its investment platform, using its own funds for equity participation or acquisitions to accelerate the product industrialization and commercialization processes of invested enterprises [1] - Additionally, the company intends to establish a BCI industry fund, leveraging the strengths and resources of professional investment institutions to expedite its industrial chain layout in the BCI and neuroscience fields [1]

证券日报网讯1月23日，振江股份（603507）在互动平台回答投资者提问时表示，公司外骨骼机器人 2025年已在国内两三家景区落地，正推进与脑机接口企业的技术协同落地；具有防松螺纹技术的紧固件 已向中航工业送审并在航空航天领域产生少量收入。公司将持续披露新业务进展，以技术突破和业绩兑 现，推动市场重塑对公司"高端装备+硬科技"的价值认知。 ...

Core Insights - The National Intellectual Property Administration of China reported significant progress in intellectual property work by 2025, exceeding the goals set in the 14th Five-Year Plan [1] Group 1: Patent Statistics - By 2025, China is expected to authorize 972,000 invention patents and 1,461,000 utility model patents, with 96,000 cases of patent reexamination and invalidation concluded [1] - The effective number of invention patents in China (excluding Hong Kong, Macau, and Taiwan) is projected to reach 5.32 million by the end of 2025, with a high-value invention patent ownership rate of 16 per 10,000 people [3] Group 2: Trademark Developments - By 2025, China aims to have 4.206 million registered trademarks and resolve 384,000 trademark review cases, with an average trademark registration review period stable at 4 months and a pass rate exceeding 97% [6] - The effective number of registered trademarks in China is expected to reach 49.877 million by the end of 2025, with the value of Chinese brands in the global top 5,000 reaching $1.81 trillion, ranking second globally [6] Group 3: Geographical Indications - The direct annual output value of geographical indication products in China is close to 1 trillion yuan, marking five consecutive years of growth and contributing to regional economic development [7] - By 2025, China will have recognized 5,066 geographical indication products and approved 7,425 registrations for collective and certification trademarks [7] Group 4: Patent Utilization and Industrialization - The patent transfer and licensing record in China is expected to reach 697,000 by 2025, a year-on-year increase of 13.7%, with nearly 90,000 of these from universities and research institutions, reflecting a 16.6% increase [8] - The industrialization rate of enterprise invention patents is projected to reach 54% by 2025, indicating steady growth over the years [8] Group 5: Artificial Intelligence and Future Technologies - China has 2.292 million high-value invention patents, with the fastest growth in fields such as information technology management, computer technology, and medical technology, positioning itself as a leader in artificial intelligence patents globally [9] - Key core technology patents have been laid out in future industries such as quantum technology, biomanufacturing, brain-computer interfaces, and sixth-generation communications [9] Group 6: Public Service Network - During the 14th Five-Year Plan period, China has established a diverse and multi-dimensional public service network, with 519 national-level intellectual property public service institutions covering all provincial levels [10] - In collaboration with the World Intellectual Property Organization, China has built the largest and most comprehensive Technology and Innovation Support Center (TISC) network globally, with 202 centers [10] - Various public service institutions have served over 5 million innovation entities during the 14th Five-Year Plan period [12]